GleamWall
中文EN

SCND SCIENTIFIC INDUSTRIES INC

Laboratory Analytical Instruments · OTC · SEC CIK 87802 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY20.6%
TTM net income YoY-244.6%
TTM EPS YoY-208.3%
Revenue 3-yr CAGR-19.6%
Net income 3-yr CAGR—

Margins

Gross margin31.3%
Operating margin-116.3%
Net margin-75.1%
FCF margin-110.6%
EBITDA margin-110.8%

Returns

ROE-40.4%
ROA-33.5%
ROIC (approx.)-56.1%
Asset turnover0.45x

Leverage & solvency

Liabilities / assets20.7%
Debt / equity0.00x
Current ratio6.43x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.46x
Accruals ratio15.4%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.35M$1.47M$1.23M$1.63M$1.40M$1.08M$942,300$1.28M
Cost of revenue$611,900$847,700$757,200$1.69M$765,400$704,300$598,000$827,400
Gross profit$742,900$622,700$469,900-$59,900$638,600$376,700$344,300$455,100
R&D expense$662,200$694,500$703,700$616,800$621,400$677,100$652,000$951,900
SG&A expense$677,200$553,900$746,900$697,400$803,600$744,800$1.03M$1.24M
Operating income-$1.21M-$1.27M-$1.67M-$2.46M-$1.52M-$1.82M-$2.09M-$2.53M
Pretax income$509,800-$1.23M-$1.59M-$1.92M$4.00M-$1.80M-$2.06M-$2.51M
Income tax$39,800$0$0-$10,700$15,300$0$0$0
Net income$470,000-$1.23M-$1.59M-$1.91M$3.99M-$1.52M-$1.78M-$1.93M
EBITDA-$1.16M-$1.22M-$1.61M-$2.30M-$1.39M-$1.67M-$1.92M-$2.35M
EPS (diluted)0.04-0.10-0.13—0.34-0.13-0.16—
Weighted avg. shares (diluted)11.93M11.93M11.93M—11.71M11.35M10.50M—
Balance sheet
Cash & equivalents$1.35M$616,500$797,800$955,000$1.16M$891,400$470,100$587,900
Short-term investments$4.62M$3.93M—$5.71M————
Receivables$395,400$517,100$535,300$865,800$677,600$966,000$1.21M$581,900
Inventory$2.17M$1.94M$1.57M$1.75M$2.04M$4.39M$4.35M$2.06M
Current assets$8.50M$8.13M$8.99M$10.39M$11.89M$7.21M$7.39M$8.29M
PP&E, net$570,600$604,400$637,600$690,900$765,600$906,600$899,400$796,300
Goodwill$115,300$115,300$115,300$115,300$115,300$115,300$115,300$115,300
Intangibles$79,100$81,000$92,000$103,500$449,300$530,800$626,300$752,300
Total assets$10.93M$10.11M$11.10M$12.61M$14.56M$10.23M$10.57M$11.56M
Current liabilities$1.32M$1.60M$1.45M$1.35M$1.55M$1.70M$2.13M$1.75M
Total liabilities$2.26M$2.03M$1.99M$1.94M$2.10M$2.23M$2.80M$2.44M
Shareholders' equity$8.67M$8.07M$9.12M$10.66M$12.46M$7.92M$7.77M$9.12M
Shares outstanding11.93M11.93M11.93M11.93M11.93M11.55M10.50M10.50M
Cash flow statement
Operating cash flow-$577,400-$904,100-$993,500-$3.76M-$1.63M-$1.68M-$1.52M$1.14M
Capital expenditure$14,800$8,300$6,200$19,600$10,400$6,900$26,300$22,900
Free cash flow-$592,200-$912,400-$999,700-$3.78M-$1.64M-$1.69M-$1.55M$1.12M
Investing cash flow$969,600$926,700$813,900$1.39M$863,600$376,700$1.20M$436,100
Financing cash flow$0$0$0-$100$500,100$1.45M$0$0
Depreciation & amortization$56,300$50,800$55,300$151,800$137,200$154,300$166,700$185,300
Stock-based compensation$155,900$162,500$116,300$72,600$72,900$72,600$302,600$315,700

Free plan shows the latest 8 periods; Pro shows all 65 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.